1-9 of 9
Shuhong Zhang, PhD
Close
Sort by
Journal Articles

Inhibition of PIM Kinases Mitigates DNA Repair Responses Following Anthracycline-Induced DNA Damage and Enhances the Anti-Tumor Activity of Doxorubicin Against Lymphoma Cells

Jeffrey D. Altenburg, PhD, Shuhong Zhang, PhD, Michelle Grimard, Xingkui Xue, MD PhD, Sherif S Farag, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4505.
https://doi.org/10.1182/blood.V124.21.4505.4505
Published: 2014
Journal Articles

Clinical Activity of a Novel Multiple Tyrosine Kinase and Aurora Kinase Inhibitor, ENMD-2076, Against Multiple Myeloma: Interim Phase I Trial Results

Sherif Farag, MD, PhD, Shuhong Zhang, PhD, Attaya Suvannasankha, MD, Jing Liang, MD, Robyn O'Bryant, RN, Wood Lisa, RN, Sushil Gupta, PhD, Mark Bray, PhD, Carolyn Fowler Sidor, MD, Rafat Abonour, MD
Journal: Blood
Blood (2010) 116 (21): 1957.
https://doi.org/10.1182/blood.V116.21.1957.1957
Published: 2010
Journal Articles

Multiple Myeloma Derived Factors Generate Tolerogenic Dendritic Cells by Activation of STAT3: A Potential Target for Immunotherapy.

Yaser Homsi, MD, Li Chen, MD, Shuhong Zhang, PhD, Jing Liang, Attaya Suvannasankha, MD, Rafat Abonour, MD., Sherif Farag, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3031.
https://doi.org/10.1182/blood.V114.22.3031.3031
Published: 2009
Journal Articles

Enhancing Natural Killer (NK) Cell Mediated Killing of Non-Hodgkin's Lymphoma.

Shivani Srivastava, MD, Hailin Feng, Shuhong Zhang, PhD, Jing Liang, Patrick Squiban, MD, Sherif Farag, MBBS, PhD
Journal: Blood
Blood (2009) 114 (22): 2706.
https://doi.org/10.1182/blood.V114.22.2706.2706
Published: 2009
Journal Articles

IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody, and Lenalidomide Combine to Enhance the Natural Killer (NK) Cell Versus Multiple Myeloma (MM) Effect.

Don Benson, MD, PhD, Courtney E Bakan, Shuhong Zhang, PhD, Lana Alghothani, Jing Liang, Craig Hofmeister, MD, Shivani Srivastava, MD, Megan K Smith, MS, CNP, RN, Carli N Greenfield, Pascale Andre, PhD, Patrick Squiban, MD, Francois Romagne, PhD, Michael A. Caligiuri, M.D., Sherif Farag, MBBS, PhD
Journal: Blood
Blood (2009) 114 (22): 3870.
https://doi.org/10.1182/blood.V114.22.3870.3870
Published: 2009
Journal Articles

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Xiaojing Wang, PhD, Anthony L. Sinn, Attaya Suvannasankha, MD, Colin D. Crean, Li Chen, MD, Shuhong Zhang, PhD, Jing Liang, MD, Genglin Zhang, Karen E. Pollok, PhD, Rafat Abonour, MD, Carolyn Sidor, MD, Mark R. Bray, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3660.
https://doi.org/10.1182/blood.V112.11.3660.3660
Published: 2008
Journal Articles

Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells

Shuhong Zhang, PhD, Xiaojing Wang, PhD, Li Chen, Jing Liang, Attaya Suvannasankha, MD, Rafat Abonour, MD, Sherif S Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5171.
https://doi.org/10.1182/blood.V112.11.5171.5171
Published: 2008
Journal Articles

OSU03012, a Novel Celecoxib Derivative, Induces Apoptosis in Multiple Myeloma Cells Independently of Caspase Activation.

Shuhong Zhang, PhD, Valerie L. White, Amy Johnson, PhD, Ching-Shih Chen, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5075.
https://doi.org/10.1182/blood.V108.11.5075.5075
Published: 2006
Journal Articles

OSU-HDAC42, a Novel Histone Deacetylase Inhibitor, Induces Apoptosis in a Caspase-Dependent Manner and Induces p 21WAF1/CIP1 and p16 Expression in Multiple Myeloma Cell Lines.

Valerie L. White, Shuhong Zhang, PhD, David Lucas, PhD, Ching-Shih Chen, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5078.
https://doi.org/10.1182/blood.V108.11.5078.5078
Published: 2006